nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—HSD3B2—saliva-secreting gland—thyroid cancer	0.0872	0.288	CbGeAlD
Trilostane—HSD3B2—head—thyroid cancer	0.0472	0.156	CbGeAlD
Trilostane—ESR2—Nuclear Receptors—THRB—thyroid cancer	0.0395	0.0567	CbGpPWpGaD
Trilostane—ESR2—neck—thyroid cancer	0.0365	0.121	CbGeAlD
Trilostane—HSD3B2—lymph node—thyroid cancer	0.0331	0.109	CbGeAlD
Trilostane—ESR2—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.0312	0.0448	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—KRT19—thyroid cancer	0.0311	0.0445	CbGpPWpGaD
Trilostane—ESR1—neck—thyroid cancer	0.025	0.0827	CbGeAlD
Trilostane—ESR1—Nuclear Receptors—THRB—thyroid cancer	0.0199	0.0286	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.0199	0.0285	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.0184	0.0264	CbGpPWpGaD
Trilostane—ESR2—thyroid gland—thyroid cancer	0.0174	0.0574	CbGeAlD
Trilostane—ESR2—Nuclear Receptors—RXRA—thyroid cancer	0.0168	0.0241	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.0158	0.0226	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.0155	0.0222	CbGpPWpGaD
Trilostane—ESR2—head—thyroid cancer	0.0154	0.051	CbGeAlD
Trilostane—HSD3B1—Corticotropin-releasing hormone—BRAF—thyroid cancer	0.0148	0.0212	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—RET—thyroid cancer	0.0137	0.0197	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.0133	0.019	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.0128	0.0183	CbGpPWpGaD
Trilostane—ESR1—thyroid gland—thyroid cancer	0.0119	0.0393	CbGeAlD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.0118	0.0169	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—BRAF—thyroid cancer	0.0112	0.0161	CbGpPWpGaD
Trilostane—ESR2—lymph node—thyroid cancer	0.0108	0.0357	CbGeAlD
Trilostane—HSD3B1—Metabolism—MINPP1—thyroid cancer	0.0107	0.0154	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptors—PPARG—thyroid cancer	0.0106	0.0152	CbGpPWpGaD
Trilostane—ESR1—head—thyroid cancer	0.0106	0.0349	CbGeAlD
Trilostane—HSD3B1—Metabolism—NDUFA13—thyroid cancer	0.00912	0.0131	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CHST14—thyroid cancer	0.00858	0.0123	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00849	0.0122	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—RXRA—thyroid cancer	0.00847	0.0121	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—CDK1—thyroid cancer	0.00842	0.0121	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00838	0.012	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MINPP1—thyroid cancer	0.00813	0.0117	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—BRAF—thyroid cancer	0.00778	0.0112	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00746	0.0107	CbGpPWpGaD
Trilostane—ESR1—lymph node—thyroid cancer	0.00739	0.0244	CbGeAlD
Trilostane—ESR1—Nuclear signaling by ERBB4—NRG1—thyroid cancer	0.00717	0.0103	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NDUFA13—thyroid cancer	0.00691	0.00991	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—HPGD—thyroid cancer	0.00691	0.00991	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00671	0.00962	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00669	0.00959	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CHST14—thyroid cancer	0.0065	0.00932	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—NRAS—thyroid cancer	0.00611	0.00875	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.00601	0.00862	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.00561	0.00804	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CDK1—thyroid cancer	0.0056	0.00802	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—THRB—thyroid cancer	0.0054	0.00773	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—PPARG—thyroid cancer	0.00535	0.00766	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.00526	0.00753	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—HPGD—thyroid cancer	0.00524	0.00751	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.00497	0.00712	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00461	0.00661	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.00456	0.00653	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—thyroid cancer	0.00449	0.00644	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.00447	0.0064	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.00447	0.0064	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.00425	0.00609	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00423	0.00606	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—TERT—thyroid cancer	0.00413	0.00592	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.00403	0.00577	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TPR—thyroid cancer	0.00397	0.00569	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.00395	0.00565	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PRKAR1A—thyroid cancer	0.00391	0.0056	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.00386	0.00553	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00376	0.00539	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.00361	0.00517	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—TRIM33—thyroid cancer	0.00359	0.00515	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.00354	0.00507	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—CCND1—thyroid cancer	0.00351	0.00503	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—MEN1—thyroid cancer	0.00343	0.00491	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—AKT1—thyroid cancer	0.00316	0.00453	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—NRAS—thyroid cancer	0.00308	0.00441	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—CDK1—thyroid cancer	0.00301	0.00431	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TPR—thyroid cancer	0.00301	0.00431	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SLC5A5—thyroid cancer	0.00297	0.00426	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PRKAR1A—thyroid cancer	0.00296	0.00424	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.00281	0.00403	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.00279	0.00399	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—THRB—thyroid cancer	0.00272	0.0039	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.00268	0.00385	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.00267	0.00383	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—CCND1—thyroid cancer	0.00267	0.00383	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.00265	0.0038	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—THRB—thyroid cancer	0.0026	0.00372	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.0025	0.00359	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—RXRA—thyroid cancer	0.0025	0.00358	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.00243	0.00348	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.00242	0.00346	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NRG1—thyroid cancer	0.00242	0.00346	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—CCND1—thyroid cancer	0.00239	0.00342	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CCND1—thyroid cancer	0.00233	0.00334	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00233	0.00334	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—RXRA—thyroid cancer	0.00229	0.00329	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.00229	0.00329	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—TP53—thyroid cancer	0.00227	0.00325	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.00225	0.00323	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SLC5A5—thyroid cancer	0.00225	0.00323	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—PTEN—thyroid cancer	0.00225	0.00322	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—CCND1—thyroid cancer	0.00221	0.00316	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.00211	0.00303	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.00207	0.00297	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.00205	0.00295	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.002	0.00287	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.00199	0.00285	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—RXRA—thyroid cancer	0.00189	0.00271	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.00184	0.00264	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—TRIM33—thyroid cancer	0.00181	0.0026	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—TPR—thyroid cancer	0.00175	0.00252	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—MEN1—thyroid cancer	0.00173	0.00248	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.00173	0.00248	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—MEN1—thyroid cancer	0.00165	0.00236	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPARG—thyroid cancer	0.00158	0.00226	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TP53—thyroid cancer	0.00154	0.0022	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.00153	0.0022	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PPARG—thyroid cancer	0.00145	0.00207	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—HRAS—thyroid cancer	0.00139	0.00199	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.00136	0.00196	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—AKT1—thyroid cancer	0.00133	0.0019	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—THRB—thyroid cancer	0.00131	0.00188	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.00126	0.00181	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CALCB—thyroid cancer	0.00124	0.00178	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PTGS2—thyroid cancer	0.00124	0.00178	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—AKT1—thyroid cancer	0.00123	0.00176	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.00122	0.00174	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PTEN—thyroid cancer	0.00121	0.00173	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPARG—thyroid cancer	0.00119	0.00171	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TRIM33—thyroid cancer	0.00118	0.00169	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—RXRA—thyroid cancer	0.00116	0.00166	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.00116	0.00166	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.00115	0.00165	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.00115	0.00165	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—RXRA—thyroid cancer	0.0011	0.00158	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PTEN—thyroid cancer	0.00108	0.00155	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NRAS—thyroid cancer	0.00108	0.00155	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.00104	0.0015	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.00101	0.00144	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PTGS2—thyroid cancer	0.00094	0.00135	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000934	0.00134	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—KRAS—thyroid cancer	0.000929	0.00133	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—TPR—thyroid cancer	0.000885	0.00127	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—MEN1—thyroid cancer	0.000832	0.00119	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.00083	0.00119	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PTEN—thyroid cancer	0.00082	0.00117	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—HRAS—thyroid cancer	0.00079	0.00113	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TCF7L1—thyroid cancer	0.000786	0.00113	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000774	0.00111	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PPARG—thyroid cancer	0.00073	0.00105	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000701	0.001	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—AKT1—thyroid cancer	0.000697	0.000999	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PPARG—thyroid cancer	0.000697	0.000999	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000688	0.000986	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKT1—thyroid cancer	0.000623	0.000894	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000581	0.000833	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TSHR—thyroid cancer	0.000575	0.000825	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000566	0.000811	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—RXRA—thyroid cancer	0.000557	0.000798	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MEN1—thyroid cancer	0.000541	0.000775	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTCH1—thyroid cancer	0.000489	0.000701	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKT1—thyroid cancer	0.000472	0.000677	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SST—thyroid cancer	0.000447	0.000641	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CALCA—thyroid cancer	0.000431	0.000617	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CDK1—thyroid cancer	0.00039	0.000559	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PPARG—thyroid cancer	0.000351	0.000504	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NRG1—thyroid cancer	0.000313	0.000449	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TERT—thyroid cancer	0.000281	0.000403	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—AKT1—thyroid cancer	0.000276	0.000395	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HIF1A—thyroid cancer	0.000269	0.000385	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—BRAF—thyroid cancer	0.000223	0.000319	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCND1—thyroid cancer	0.000162	0.000233	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTEN—thyroid cancer	0.000157	0.000225	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NRAS—thyroid cancer	0.00014	0.0002	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—AKT1—thyroid cancer	0.000139	0.000199	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—KRAS—thyroid cancer	0.00012	0.000173	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TP53—thyroid cancer	0.000107	0.000153	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HRAS—thyroid cancer	0.000102	0.000147	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKT1—thyroid cancer	9.03e-05	0.000129	CbGpPWpGaD
